Quest Diagnostics Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones

2025.12.01 22:05

I'm PortAI, I can summarize articles.

Quest Diagnostics Inc. shares fell 2.86% to $183.77 on Monday, marking the third consecutive day of losses. The stock underperformed compared to competitors like UnitedHealth Group, IQVIA Holdings, and Centene Corp. during a generally poor trading session. Quest Diagnostics is 6.98% below its 52-week high of $197.55.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Quest Diagnostics Inc. (DGX) slid 2.86% to $183.77 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.53% to 6,812.63 and Dow Jones Industrial Average falling 0.90% to 47,289.33. This was the stock's third consecutive day of losses. Quest Diagnostics Inc. closed 6.98% short of its 52-week high of $197.55, which the company achieved on October 21st. The stock demonstrated a mixed performance when compared to some of its competitors Monday, as UnitedHealth Group Inc. (UNH) fell 1.99% to $323.21, IQVIA Holdings Inc. (IQV) fell 0.67% to $228.47, and Centene Corp. (CNC) fell 3.69% to $37.89. Data source: Dow Jones Market Data, FactSet. Data compiled December 1, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 12-01-25 1705ET